Skip to main content
NCBI home page
The Ulster Medical Journal logoLink to The Ulster Medical Journal
. 2004 May;73(Suppl):2–6.

The development of oxytocic drugs in the management of postpartum haemorrhage

Thomas F Baskett
PMCID: PMC2477906  PMID: 15239206

Full text

PDF
2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bamigboye A. A., Hofmeyr G. J., Merrell D. A. Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial. Am J Obstet Gynecol. 1998 Oct;179(4):1043–1046. doi: 10.1016/s0002-9378(98)70212-1. [DOI] [PubMed] [Google Scholar]
  2. Baskett T. F. A flux of the reds: evolution of active management of the third stage of labour. J R Soc Med. 2000 Sep;93(9):489–493. doi: 10.1177/014107680009300913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baskett Thomas F. Acute uterine inversion: a review of 40 cases. J Obstet Gynaecol Can. 2002 Dec;24(12):953–956. doi: 10.1016/s1701-2163(16)30594-1. [DOI] [PubMed] [Google Scholar]
  4. Bell W. B. THE PITUITARY BODY AND THE THERAPEUTIC VALUE OF THE INFUNDIBULAR EXTRACT IN SHOCK, UTERINE ATONY, AND INTESTINAL PARESIS. Br Med J. 1909 Dec 4;2(2553):1609–1613. doi: 10.1136/bmj.2.2553.1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bygdeman M., Kwon S. U., Mukherjee T., Wiqvist N. Effect of intravenous infusion of prostaglandin E1 and E2 on motility of the pregnant human uterus. Prostaglandins and related factors 65. Am J Obstet Gynecol. 1968 Oct 1;102(3):317–326. doi: 10.1016/0002-9378(68)90001-x. [DOI] [PubMed] [Google Scholar]
  6. Collins P. W. Misoprostol: discovery, development, and clinical applications. Med Res Rev. 1990 Apr-Jun;10(2):149–172. doi: 10.1002/med.2610100202. [DOI] [PubMed] [Google Scholar]
  7. Corson S. L., Bolognese R. J. Postpartum uterine atony treated with prostaglandins. Am J Obstet Gynecol. 1977 Dec 15;129(8):918–919. doi: 10.1016/0002-9378(77)90526-9. [DOI] [PubMed] [Google Scholar]
  8. DALEY D. The use of intramuscular ergometrine at the end of the second stage of normal labour. J Obstet Gynaecol Br Emp. 1951 Jun;58(3):388–397. doi: 10.1111/j.1471-0528.1951.tb04012.x. [DOI] [PubMed] [Google Scholar]
  9. Dale H. H. The Action of Extracts of the Pituitary Body. Biochem J. 1909;4(9):427–447. doi: 10.1042/bj0040427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Elbourne D., Prendiville W., Chalmers I. Choice of oxytocic preparation for routine use in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol. 1988 Jan;95(1):17–30. doi: 10.1111/j.1471-0528.1988.tb06476.x. [DOI] [PubMed] [Google Scholar]
  11. Hayashi R. H., Castillo M. S., Noah M. L. Management of severe postpartum hemorrhage due to uterine atony using an analogue of prostaglandin F2 alpha. Obstet Gynecol. 1981 Oct;58(4):426–429. [PubMed] [Google Scholar]
  12. Karim S. M., Sharma S. D., Filshie G. M. Termination of pregnancy with 15 methyl analogues of prostaglandins E 2 and F 2 . J Reprod Med. 1972 Dec;9(6):383–391. [PubMed] [Google Scholar]
  13. MOIR J. C. The history and present-day use of ergot. Can Med Assoc J. 1955 May 15;72(10):727–734. [PMC free article] [PubMed] [Google Scholar]
  14. O'Brien P., El-Refaey H., Gordon A., Geary M., Rodeck C. H. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol. 1998 Aug;92(2):212–214. doi: 10.1016/s0029-7844(98)00161-6. [DOI] [PubMed] [Google Scholar]
  15. Prendiville W., Elbourne D., Chalmers I. The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol. 1988 Jan;95(1):3–16. doi: 10.1111/j.1471-0528.1988.tb06475.x. [DOI] [PubMed] [Google Scholar]
  16. SHAW D. A. F. Oxytocic drugs in the third stage of labour. J Obstet Gynaecol Br Emp. 1949 Oct;56(5):833–837. doi: 10.1111/j.1471-0528.1949.tb07149.x. [DOI] [PubMed] [Google Scholar]
  17. Takagi S., Yoshida T., Togo Y., Tochigi H., Abe M., Sakata H., Fujii T. K., Takahashi H., Tochigi B. The effects of intramyometrial injection of prostaglandin F2alpha on severe post-partum hemorrhage. Prostaglandins. 1976 Oct;12(4):565–579. doi: 10.1016/0090-6980(76)90037-x. [DOI] [PubMed] [Google Scholar]
  18. V Euler U. S. An adrenaline-like action in extracts from the prostatic and related glands. J Physiol. 1934 Mar 29;81(1):102–112. doi: 10.1113/jphysiol.1934.sp003119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Villar J., Gülmezoglu A. M., Hofmeyr G. Justus, Forna F. Systematic review of randomized controlled trials of misoprostol to prevent postpartum hemorrhage. Obstet Gynecol. 2002 Dec;100(6):1301–1312. doi: 10.1016/s0029-7844(02)02371-2. [DOI] [PubMed] [Google Scholar]
  20. el-Refaey H., O'Brien P., Morafa W., Walder J., Rodeck C. Use of oral misoprostol in the prevention of postpartum haemorrhage. Br J Obstet Gynaecol. 1997 Mar;104(3):336–339. doi: 10.1111/j.1471-0528.1997.tb11464.x. [DOI] [PubMed] [Google Scholar]
  21. von Euler U. S. On the specific vaso-dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin). J Physiol. 1936 Nov 6;88(2):213–234. doi: 10.1113/jphysiol.1936.sp003433. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Ulster Medical Journal are provided here courtesy of Ulster Medical Society

RESOURCES